Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters











Publication year range
1.
Int J Biol Macromol ; 164: 3508-3522, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-32858106

ABSTRACT

Vibrio campbellii (formerly Vibrio harveyi) is a bacterial pathogen that causes vibriosis, which devastates fisheries and aquaculture worldwide. V. campbellii expresses chitinolytic enzymes and chitin binding/transport proteins, which serve as excellent targets for antimicrobial agent development. We previously characterized VhChiP, a chitooligosaccharide-specific porin from the outer membrane of V. campbellii BAA-1116. This study employed far-UV circular dichroism and tryptophan fluorescence spectroscopy, together with single channel electrophysiology to demonstrate that the strong binding of chitoligosaccharides enhanced thermal stability of VhChiP. The alanine substitution of Trp136 at the center of the affinity sites caused a marked decrease in the binding affinity and decreased the thermal stability of VhChiP. Tryptophan fluorescence titrations over a range of temperatures showed greater free-energy changes on ligand binding (ΔG°binding) with increasing chain length of the chitooligosaccharides. Our findings suggest the possibility of designing stable channel-blockers, using sugar-based analogs that serve as antimicrobial agents, active against Vibrio infection.


Subject(s)
Bacterial Outer Membrane Proteins/chemistry , Porins/chemistry , Vibrio , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacterial Outer Membrane Proteins/antagonists & inhibitors , Bacterial Outer Membrane Proteins/genetics , Binding Sites , Drug Development , Gene Expression , Models, Molecular , Molecular Structure , Molecular Weight , Porins/antagonists & inhibitors , Porins/genetics , Protein Binding , Protein Stability , Protein Unfolding , Recombinant Proteins , Spectrum Analysis , Structure-Activity Relationship , Thermodynamics , Vibrio/drug effects , Vibrio/genetics , Vibrio/metabolism , Vibrio Infections/drug therapy , Vibrio Infections/microbiology
2.
Biophys Chem ; 266: 106456, 2020 11.
Article in English | MEDLINE | ID: mdl-32835912

ABSTRACT

Under the present investigation, effect of ciprofloxacin (CIP) on Escherichia coli has been investigated using electrochemical, spectroscopic and atomic force microscope (AFM) measurements. Investigation reveals the interaction pattern of CIP with E. coli. The CIP essentially interacts with the outer membrane protein F (OmpF), the formation constant of the complex forms between CIP and the OmpF active sites over E. coli is obtained as log Kf of 12.1. Spectroscopic measurements are carried out, which supports the electrochemical measurements on the interaction between CIP and E. coli, at a higher concentration, CIP induces lysis of the E. coli cell membrane. Spectroscopic investigations further reveals that the FeS containing proteins present inside the E. coli cells released out through the ruptured cell membrane of E. coli. Different degrees of detrimental effects on E. coli has been observed when exposed to different concentrations of the drugs. The microscopic images obtained from the AFM scans of E. coli in presence of CIP shows deformation of the E. coli cell wall and its rupture with increasing concentrations of CIP.


Subject(s)
Anti-Bacterial Agents/chemistry , Ciprofloxacin/chemistry , Escherichia coli/chemistry , Anti-Bacterial Agents/pharmacology , Ciprofloxacin/pharmacology , Electrochemical Techniques , Escherichia coli/cytology , Escherichia coli/drug effects , Microbial Sensitivity Tests , Microscopy, Atomic Force , Molecular Structure , Porins/antagonists & inhibitors , Porins/chemistry , Spectrophotometry
3.
Sci Rep ; 7(1): 6722, 2017 07 27.
Article in English | MEDLINE | ID: mdl-28751669

ABSTRACT

Klebsiella pneumoniae, an Enterobacteriaceae that mostly causes hospital-acquired infections, belongs to the recently published WHO's list of antibiotic-resistant pathogens that pose the greatest threat to human health. Indeed, K. pneumoniae is the enterobacterial species most concerned by both resistance to extended-spectrum cephalosporins, due to extended-spectrum ß-lactamase (ESBL) production, and resistance to carbapenems, i.e. the ß-lactams with the broadest activity. Carbapenem resistance is related not only to carbapenemase production, but also the production of ESBL or AmpC and the loss of general porins. Here, we characterized the mechanisms that deprived a urinary ESBL-producing, porin-deficient K. pneumoniae isolate, isolated 13 days after the end of a 40-day course of imipenem treatment, of its carbapenem resistance. These mechanisms were observed in two in-vivo derivatives of this isolate and consisted of mutations in genes encoding molecules that participate in the downregulation of the synthesis of PhoE, a porin specialized in phosphate transport. We obtained three new derivatives from one of the two original derivatives, following in-vitro antibiotic pressure, in which the carbapenem resistance was restored because of mutations in genes encoding molecules that participate in the upregulation of PhoE synthesis. Thus, we uncovered novel mechanisms of carbapenem resistance/susceptibility switching in K. pneumoniae.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/drug effects , Gene Expression Regulation, Bacterial , Genome, Bacterial , Klebsiella pneumoniae/drug effects , Porins/genetics , Aminoglycosides/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Carbapenems/pharmacology , Cephalosporins/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Female , Humans , Klebsiella Infections/drug therapy , Klebsiella Infections/microbiology , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/growth & development , Klebsiella pneumoniae/isolation & purification , Middle Aged , Mutation , Nitrobenzenes/pharmacology , Penicillins/pharmacology , Porins/antagonists & inhibitors , Porins/metabolism , Tetracyclines/pharmacology , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , beta-Lactamases/genetics , beta-Lactamases/metabolism
4.
Sci Rep ; 7: 40208, 2017 01 16.
Article in English | MEDLINE | ID: mdl-28091521

ABSTRACT

The ß-lactam antibiotic temocillin (6-α-methoxy-ticarcillin) shows stability to most extended spectrum ß-lactamases, but is considered inactive against Pseudomonas aeruginosa. Mutations in the MexAB-OprM efflux system, naturally occurring in cystic fibrosis (CF) isolates, have been previously shown to reverse this intrinsic resistance. In the present study, we measured temocillin activity in a large collection (n = 333) of P. aeruginosa CF isolates. 29% of the isolates had MICs ≤ 16 mg/L (proposed clinical breakpoint for temocillin). Mutations were observed in mexA or mexB in isolates for which temocillin MIC was ≤512 mg/L (nucleotide insertions or deletions, premature termination, tandem repeat, nonstop, and missense mutations). A correlation was observed between temocillin MICs and efflux rate of N-phenyl-1-naphthylamine (MexAB-OprM fluorescent substrate) and extracellular exopolysaccharide abundance (contributing to a mucoid phenotype). OpdK or OpdF anion-specific porins expression decreased temocillin MIC by ~1 two-fold dilution only. Contrarily to the common assumption that temocillin is inactive on P. aeruginosa, we show here clinically-exploitable MICs on a non-negligible proportion of CF isolates, explained by a wide diversity of mutations in mexA and/or mexB. In a broader context, this work contributes to increase our understanding of MexAB-OprM functionality and help delineating how antibiotics interact with MexA and MexB.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cystic Fibrosis/complications , Penicillins/pharmacology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , 1-Naphthylamine/analogs & derivatives , 1-Naphthylamine/metabolism , Bacterial Outer Membrane Proteins/genetics , Biological Transport , Biological Variation, Population , DNA Mutational Analysis , Humans , Membrane Transport Proteins/genetics , Microbial Sensitivity Tests , Mutation , Polysaccharides, Bacterial/metabolism , Porins/antagonists & inhibitors
5.
Drug Resist Updat ; 28: 82-90, 2016 09.
Article in English | MEDLINE | ID: mdl-27620956

ABSTRACT

The genus Burkholderia comprises metabolically diverse and adaptable Gram-negative bacteria, which thrive in often adversarial environments. A few members of the genus are prominent opportunistic pathogens. These include Burkholderia mallei and Burkholderia pseudomallei of the B. pseudomallei complex, which cause glanders and melioidosis, respectively. Burkholderia cenocepacia, Burkholderia multivorans, and Burkholderia vietnamiensis belong to the Burkholderia cepacia complex and affect mostly cystic fibrosis patients. Infections caused by these bacteria are difficult to treat because of significant antibiotic resistance. The first line of defense against antimicrobials in Burkholderia species is the outer membrane penetration barrier. Most Burkholderia contain a modified lipopolysaccharide that causes intrinsic polymyxin resistance. Contributing to reduced drug penetration are restrictive porin proteins. Efflux pumps of the resistance nodulation cell division family are major players in Burkholderia multidrug resistance. Third and fourth generation ß-lactam antibiotics are seminal for treatment of Burkholderia infections, but therapeutic efficacy is compromised by expression of several ß-lactamases and ceftazidime target mutations. Altered DNA gyrase and dihydrofolate reductase targets cause fluoroquinolone and trimethoprim resistance, respectively. Although antibiotic resistance hampers therapy of Burkholderia infections, the characterization of resistance mechanisms lags behind other non-enteric Gram-negative pathogens, especially ESKAPE bacteria such as Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa.


Subject(s)
Anti-Bacterial Agents/pharmacology , Burkholderia mallei/drug effects , Burkholderia pseudomallei/drug effects , Burkholderia/drug effects , Drug Resistance, Multiple, Bacterial/genetics , Gene Expression Regulation, Bacterial , Genes, MDR , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Burkholderia/genetics , Burkholderia/growth & development , Burkholderia/pathogenicity , Burkholderia Infections/drug therapy , Burkholderia Infections/microbiology , Burkholderia Infections/pathology , Burkholderia mallei/genetics , Burkholderia mallei/growth & development , Burkholderia mallei/pathogenicity , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/growth & development , Burkholderia pseudomallei/pathogenicity , DNA Gyrase/genetics , DNA Gyrase/metabolism , Glanders/drug therapy , Glanders/microbiology , Glanders/pathology , Horses , Humans , Melioidosis/drug therapy , Melioidosis/microbiology , Melioidosis/pathology , Porins/antagonists & inhibitors , Porins/genetics , Porins/metabolism , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism
6.
Pathog Dis ; 74(2)2016 Mar.
Article in English | MEDLINE | ID: mdl-26656888

ABSTRACT

Emergent rational drug design techniques explore individual properties of target biomolecules, small and macromolecule drug candidates, and the physical forces governing their interactions. In this minireview, we focus on the single-molecule biophysical studies of channel-forming bacterial toxins that suggest new approaches for their inhibition. We discuss several examples of blockage of bacterial pore-forming and AB-type toxins by the tailor-made compounds. In the concluding remarks, the most effective rationally designed pore-blocking antitoxins are compared with the small-molecule inhibitors of ion-selective channels of neurophysiology.


Subject(s)
Antitoxins/pharmacology , Bacterial Toxins/antagonists & inhibitors , Drug Design , Antitoxins/chemistry , Antitoxins/classification , Bacterial Toxins/chemistry , Bacterial Toxins/classification , Drug Discovery , Inhibitory Concentration 50 , Porins/antagonists & inhibitors , Porins/chemistry , Porins/metabolism , Structure-Activity Relationship
7.
Nature ; 505(7481): 103-7, 2014 Jan 02.
Article in English | MEDLINE | ID: mdl-24256734

ABSTRACT

Human body-surface epithelia coexist in close association with complex bacterial communities and are protected by a variety of antibacterial proteins. C-type lectins of the RegIII family are bactericidal proteins that limit direct contact between bacteria and the intestinal epithelium and thus promote tolerance to the intestinal microbiota. RegIII lectins recognize their bacterial targets by binding peptidoglycan carbohydrate, but the mechanism by which they kill bacteria is unknown. Here we elucidate the mechanistic basis for RegIII bactericidal activity. We show that human RegIIIα (also known as HIP/PAP) binds membrane phospholipids and kills bacteria by forming a hexameric membrane-permeabilizing oligomeric pore. We derive a three-dimensional model of the RegIIIα pore by docking the RegIIIα crystal structure into a cryo-electron microscopic map of the pore complex, and show that the model accords with experimentally determined properties of the pore. Lipopolysaccharide inhibits RegIIIα pore-forming activity, explaining why RegIIIα is bactericidal for Gram-positive but not Gram-negative bacteria. Our findings identify C-type lectins as mediators of membrane attack in the mucosal immune system, and provide detailed insight into an antibacterial mechanism that promotes mutualism with the resident microbiota.


Subject(s)
Anti-Bacterial Agents/metabolism , Antigens, Neoplasm/metabolism , Biomarkers, Tumor/metabolism , Intestines/chemistry , Lectins, C-Type/metabolism , Porins/metabolism , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/immunology , Anti-Bacterial Agents/pharmacology , Antigens, Neoplasm/chemistry , Antigens, Neoplasm/immunology , Biomarkers, Tumor/antagonists & inhibitors , Biomarkers, Tumor/chemistry , Biomarkers, Tumor/immunology , Cell Membrane Permeability/drug effects , Cryoelectron Microscopy , Crystallography, X-Ray , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/immunology , Gram-Negative Bacteria/metabolism , Humans , Immunity, Mucosal/drug effects , Immunity, Mucosal/immunology , Intestines/immunology , Intestines/microbiology , Lectins, C-Type/antagonists & inhibitors , Lectins, C-Type/chemistry , Lectins, C-Type/immunology , Lipopolysaccharides/pharmacology , Listeria monocytogenes/drug effects , Listeria monocytogenes/immunology , Listeria monocytogenes/metabolism , Microbial Viability/drug effects , Models, Molecular , Pancreatitis-Associated Proteins , Peptidoglycan/metabolism , Phospholipids/metabolism , Porins/antagonists & inhibitors , Porins/chemistry , Symbiosis
8.
Neuron ; 77(2): 274-87, 2013 Jan 23.
Article in English | MEDLINE | ID: mdl-23352164

ABSTRACT

Voltage-gated sodium, potassium, and calcium channels are made of a pore domain (PD) controlled by four voltage-sensing domains (VSDs). The PD contains the ion permeation pathway and the activation gate located on the intracellular side of the membrane. A large number of small molecules are known to inhibit the PD by acting as open channel blockers. The voltage-gated proton channel Hv1 is made of two VSDs and lacks the PD. The location of the activation gate in the VSD is unknown and open channel blockers for VSDs have not yet been identified. Here, we describe a class of small molecules which act as open channel blockers on the Hv1 VSD and find that a highly conserved phenylalanine in the charge transfer center of the VSD plays a key role in blocker binding. We then use one of the blockers to show that Hv1 contains two intracellular and allosterically coupled gates.


Subject(s)
Ion Channel Gating/physiology , Ion Channels/chemistry , Ion Channels/physiology , Porins/chemistry , Porins/physiology , Animals , Conserved Sequence/genetics , Female , Humans , Ion Channels/antagonists & inhibitors , Phenylalanine/chemistry , Phenylalanine/physiology , Porins/antagonists & inhibitors , Protein Binding/physiology , Protein Structure, Tertiary , Xenopus
10.
Biochim Biophys Acta ; 1818(11): 2777-82, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22789813

ABSTRACT

Porins are channel-forming proteins that are located in the outer membranes (OM) of Gram-negative bacteria and allow the influx of hydrophilic nutrients and the extrusion of waste products. The fine regulation of the ion transport through these wide channels could play an important role in the survival of the bacteria in acidic media. We investigate here the mechanism responsible for the pH sensitivity of the trimeric porin OmpF, of Escherichia coli. Planar lipid bilayer electrophysiology and site-directed mutagenesis were used to study the effect of pH on the ion conductive properties of the OmpF channel in its fully open, "nongated" conformation. At low pH we observe a large drop in the OmpF open channel conductance that is accompanied by a substantial increase of the current noise. These channel features are strongly dependent on the salt concentration and we propose that they are originated by competitive binding of cations and protons occurring in the narrow central constriction of the channel. This subtle mechanism reveals to be capital for the channel function because it not only drives the channel sensitivity to pH but is also indispensable for the particularly efficient permeation mechanism of the channel at physiological conditions (~neutral pH).


Subject(s)
Porins/antagonists & inhibitors , Protons , Salts/chemistry , Escherichia coli/chemistry , Hydrogen-Ion Concentration , Porins/chemistry , Potassium/chemistry
11.
J Gen Physiol ; 140(1): 69-82, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22689827

ABSTRACT

One major determinant of the efficacy of antibiotics on gram-negative bacteria is the passage through the outer membrane. During transport of the fluoroquinolone enrofloxacin through the trimeric outer membrane protein OmpF of Escherichia coli, the antibiotic interacts with two binding sites within the pore, thus partially blocking the ionic current. The modulation of one affinity site by Mg(2+) reveals further details of binding sites and binding kinetics. At positive membrane potentials, the slow blocking events induced by enrofloxacin in Mg(2+)-free media are converted to flickery sojourns at the highest apparent current level (all three pores flickering). This indicates weaker binding in the presence of Mg(2+). Analysis of the resulting amplitude histograms with ß distributions revealed the rate constants of blocking (k(OB)) and unblocking (k(BO)) in the range of 1,000 to 120,000 s(-1). As expected for a bimolecular reaction, k(OB) was proportional to blocker concentration and k(BO) independent of it. k(OB) was approximately three times lower for enrofloxacin coming from the cis side than from the trans side. The block was not complete, leading to a residual conductivity of the blocked state being ∼25% of that of the open state. Interpretation of the results has led to the following model: fast flickering as caused by interaction of Mg(2+) and enrofloxacin is related to the binding site at the trans side, whereas the cis site mediates slow blocking events which are also found without Mg(2+). The difference in the accessibility of the binding sites also explains the dependency of k(OB) on the side of enrofloxacin addition and yields a means of determining the most plausible orientation of OmpF in the bilayer. The voltage dependence suggests that the dipole of the antibiotic has to be adequately oriented to facilitate binding.


Subject(s)
Anti-Bacterial Agents/pharmacology , Fluoroquinolones/pharmacology , Porins/chemistry , Binding Sites , Enrofloxacin , Ion Channel Gating/drug effects , Lipid Bilayers/chemistry , Magnesium/metabolism , Models, Molecular , Patch-Clamp Techniques , Porins/antagonists & inhibitors , Porins/metabolism
12.
Foodborne Pathog Dis ; 9(6): 549-55, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22571640

ABSTRACT

The objective of this study was to characterize the epidemiology of Salmonella carried by dairy cows culled from herds in the Texas High Plains. Feces were collected from a convenience sample of 706 animals culled from nine dairy farms. In addition, individually paired fecal and hide samples were collected from 70 healthy milking cows on three of the dairies. Samples were cultured for Salmonella using routine methods; isolates were serotyped and subjected to a panel of antimicrobial drugs to determine susceptibility. Salmonella was recovered from 32.6% of culled cows. Whole-herd use of a vaccine containing siderophore receptors and porin proteins was associated (p=0.05) with reduced Salmonella prevalence in that the prevalence among herds that practiced whole-herd vaccination was 8.0% compared to 36.8% among herds that did not use this vaccine. The majority (88.6%) of isolates were pansusceptible or resistant to one drug. Of the 3.1% of isolates resistant to more than four drugs, all were Salmonella Newport and were recovered from one dairy. Various serotypes were recovered from individual fecal and hide samples. Salmonella Montevideo was recovered more frequently (p<0.01) from hide samples, whereas Salmonella Cerro was recovered more frequently (p<0.01) from feces. Salmonella was recovered from at least one cow on all dairies. While our study was not a priori designed to address herd-level factors, we found evidence that the whole-herd use of a siderophore receptor and porin protein-containing vaccine might be a useful aid in the control of Salmonella in groups of cattle. As this is a nonrandomized evaluation of an intervention, other herd-level factors that may be correlated with vaccine use, such as biosecurity, might have been responsible for the observed association.


Subject(s)
Bacterial Vaccines/immunology , Cattle/microbiology , Dairying , Drug Resistance, Bacterial , Salmonella/classification , Salmonella/isolation & purification , Animals , Anti-Bacterial Agents/pharmacology , Bacterial Load/veterinary , Bacterial Outer Membrane Proteins/antagonists & inhibitors , Bacterial Proteins/antagonists & inhibitors , Cattle/immunology , Drug Resistance, Multiple, Bacterial , Feces/microbiology , Immunity, Herd , Microbial Sensitivity Tests/veterinary , Porins/antagonists & inhibitors , Receptors, Cell Surface/antagonists & inhibitors , Salmonella/drug effects , Serotyping/veterinary , Skin/microbiology , Texas
13.
ACS Synth Biol ; 1(1): 6-13, 2012 Jan 20.
Article in English | MEDLINE | ID: mdl-23651005

ABSTRACT

It has become increasingly evident that noncoding small RNAs (sRNAs) play a significant and global role in bacterial gene regulation. A majority of the trans-acting sRNAs in bacteria interact with the 5' untranslated region (UTR) and/or the translation initiation region of the targeted mRNAs via imperfect base pairing, resulting in reduced translation efficiency and/or mRNA stability. Additionally, bacterial sRNAs often contain distinct scaffolds that recruit RNA chaperones such as Hfq to facilitate gene regulation. In this study, we describe a strategy to engineer artificial sRNAs that can regulate desired endogenous genes in Escherichia coli. Using a fluorescent reporter gene that was translationally fused to a native 5' mRNA leader sequence, active artificial sRNAs were screened from libraries in which natural sRNA scaffolds were fused to a randomized antisense domain. Artificial sRNAs that posttranscriptionally repress two endogenous genes ompF and fliC were isolated and characterized. We anticipate that the artificial sRNAs will be useful for dynamic control and fine-tuning of endogenous gene expression in bacteria for applications in synthetic biology.


Subject(s)
Escherichia coli/genetics , Gene Silencing , Genes, Synthetic , 5' Untranslated Regions , Base Sequence , Gene Expression Regulation, Bacterial , Genes, Bacterial , Genetic Engineering , Porins/antagonists & inhibitors , Porins/genetics , RNA/genetics , RNA, Bacterial/genetics , RNA, Small Untranslated/genetics , Synthetic Biology
14.
Mol Membr Biol ; 28(1): 69-78, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21067451

ABSTRACT

During infection, the enteric pathogen Vibrio cholerae encounters a bile-containing environment. Previous studies have shown that bile and/or bile acids exert several effects on the virulence and physiology of the bacterial cells. These observations have led to the suggestion that bile acids may play a signaling role in infection. We have previously reported that the bile component deoxycholic acid blocks the general diffusion porin OmpT in a dose-dependent manner, presumably as it transits through the pore. V. cholerae colonizes the distal jejunum and ileum, where a mixture of various conjugated and unconjugated bile acids are found. In this work, we have used patch clamp electrophysiology to investigate the effects of six bile acids on OmpT. Two bile acids (deoxycholic and chenodeoxycholic acids) were found to block OmpT at physiological concentrations below 1 mM, while glycodeoxycholic acid was mildly effective and cholic, lithocholic and taurodeoxycholic acids were ineffective in this range. The block was also voltage-dependent. These observations suggest the presence of a specific binding site inside the OmpT pore. Since deconjugation is due to the activity of the endogenous flora, the preferential uptake of some unconjugated bile acids by OmpT may signal the presence of a hospitable environment. The results are also discussed in terms of the possible molecular interactions between the penetrating bile acid molecule and the channel wall.


Subject(s)
Bacterial Proteins/metabolism , Bile Acids and Salts/pharmacology , Porins/metabolism , Vibrio cholerae/drug effects , Vibrio cholerae/metabolism , Bacterial Outer Membrane Proteins/antagonists & inhibitors , Bacterial Outer Membrane Proteins/metabolism , Bacterial Proteins/antagonists & inhibitors , Bile Acids and Salts/metabolism , Binding Sites , Models, Molecular , Patch-Clamp Techniques , Porins/antagonists & inhibitors
15.
J Bacteriol ; 191(14): 4671-3, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19429613

ABSTRACT

Burkholderia spp. that degrade phthalate have an ABC transporter-type phthalate transport system (OphFGH) and a specific porin (OphP) in addition to a permease-type phthalate transporter (OphD). OphFGH has a lower K(m) and higher V(max) than OphD, which affects how the bacteria grow. OphP is involved in both mechanisms of transport.


Subject(s)
Bacterial Proteins/metabolism , Burkholderia/metabolism , Membrane Transport Proteins/metabolism , Phthalic Acids/metabolism , Antimetabolites/pharmacology , Bacterial Proteins/genetics , Burkholderia/genetics , Burkholderia/growth & development , Cloning, Molecular , Gene Knockout Techniques , Gene Order , Kinetics , Membrane Transport Proteins/genetics , Operon , Organic Anion Transporters/metabolism , Porins/antagonists & inhibitors , Porins/genetics , Porins/metabolism
16.
Expert Opin Ther Targets ; 13(4): 385-94, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19335062

ABSTRACT

BACKGROUND: Malaria is caused by the intracellular parasite Plasmodium falciparum. The constant need for novel malaria therapies is due to the development of resistance against existing drugs. OBJECTIVE: To summarise attempts to investigate parasitic aquaporins as drug targets in malaria. METHODS: Starting with a summary of the history of malaria we present aquaporin structure and function relationships. Potential interactions of inhibitors with plasmodial AQP (PfAQP) are discussed. PfAQP blockage is examined in the light of recent work on knock-out parasites. Since PfAQP is able to transport other small solutes the parasites are sensitive to other compounds which are harmless to the human host. RESULTS/CONCLUSIONS: Total blockage of PfAQP may not lead to the death of the parasite but application of PfAQP as a vehicle for toxic substances may be a further pathway for research.


Subject(s)
Antimalarials/pharmacology , Plasmodium falciparum/drug effects , Porins/drug effects , Protozoan Proteins/drug effects , Animals , Antimalarials/pharmacokinetics , Biological Transport/drug effects , Cytotoxins/pharmacokinetics , Dihydroxyacetone/pharmacology , Drug Delivery Systems , Drug Design , Drug Evaluation, Preclinical , Drug Resistance , Glycerol/pharmacology , Humans , Hydroxyurea/pharmacokinetics , Mice , Porins/antagonists & inhibitors , Porins/chemistry , Protozoan Proteins/antagonists & inhibitors , Protozoan Proteins/chemistry , Tetraethylammonium/pharmacology , Water/metabolism
17.
Infect Immun ; 75(9): 4364-72, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17591786

ABSTRACT

Treponema denticola is an anaerobic spirochete strongly associated with human periodontal disease. T. denticola bacteria interact with a range of host tissue proteins, including fibronectin, laminin, and fibrinogen. The latter localizes in the extracellular matrix where tissue damage has occurred, and interactions with fibrinogen may play a key role in T. denticola colonization of the damaged sites. T. denticola ATCC 35405 showed saturable binding of fluid-phase fibrinogen to the cell surface and saturable adherence to immobilized fibrinogen. Levels of fibrinogen binding were enhanced in the presence of the serine protease inhibitor phenylmethylsulfonyl fluoride. The Aalpha and Bbeta chains of fibrinogen, but not the gamma chains, were specifically recognized by T. denticola. Following fibrinogen affinity chromatography analysis of cell surface extracts, a major fibrinogen-binding component (polypeptide molecular mass, approximately 100 kDa), which also degraded fibrinogen, was purified. Upon heating at 100 degrees C, the polypeptide was dissociated into three components (apparent molecular masses, 80, 48, and 45 kDa) that did not individually bind or degrade fibrinogen. The native 100-kDa polypeptide complex was identified as chymotrypsin-like protease (CTLP), or dentilisin. In an isogenic CTLP(-) mutant strain, CKE, chymotrypsin-like activity was reduced >90% compared to that in the wild type and fibrinogen binding and hydrolysis were ablated. Isogenic mutant strain MHE, deficient in the production of Msp (major surface protein), showed levels of CTLP reduced 40% relative to those in the wild type and exhibited correspondingly reduced levels of fibrinogen binding and proteolysis. Thrombin clotting times in the presence of wild-type T. denticola cells, but not strain CKE (CTLP(-)) cells, were extended. These results suggest that interactions of T. denticola with fibrinogen, which may promote colonization and modulate hemostasis, are mediated principally by CTLP.


Subject(s)
Bacterial Adhesion/physiology , Chymases/physiology , Chymotrypsin/physiology , Fibrin Fibrinogen Degradation Products/metabolism , Fibrinogen/metabolism , Hemostasis/physiology , Treponema denticola/enzymology , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/metabolism , Chymases/antagonists & inhibitors , Chymotrypsin/antagonists & inhibitors , Chymotrypsin/blood , Fibrin Fibrinogen Degradation Products/antagonists & inhibitors , Fibrin Fibrinogen Degradation Products/physiology , Fibrinogen/physiology , Humans , Multiprotein Complexes/antagonists & inhibitors , Multiprotein Complexes/metabolism , Multiprotein Complexes/physiology , Peptide Hydrolases , Porins/antagonists & inhibitors , Porins/metabolism , Treponema denticola/growth & development , Treponema denticola/physiology
18.
J Biol Chem ; 281(29): 19899-905, 2006 Jul 21.
Article in English | MEDLINE | ID: mdl-16670088

ABSTRACT

OmpT and OmpU are general diffusion porins of the human intestinal pathogen Vibrio cholerae. The sole presence of OmpT in the outer membrane sensitizes cells to the bile component deoxycholic acid, and the repression of OmpT in the intestine may play an important role in the adaptation of cells to the host environment. Here we report a novel important functional difference between the two porins, namely the sensitivity to deoxycholic acid. Single channel recordings show that submicellar concentrations of sodium deoxycholate induce time-resolved blocking events of OmpT but are devoid of any effect on OmpU. The effects are dose-, voltage-, and pH-dependent. They are elicited by deoxycholate applied to either side of the membrane, with some asymmetry in the sensitivity. The voltage dependence remains even when deoxycholate is applied symmetrically, indicating that it is intrinsic to the binding site. The pH dependence suggests that the active form is the neutral deoxycholic acid and not the negatively charged species. The results are interpreted as deoxycholic acid acting as an open-channel blocker, which may relate to deoxycholic acid permeation.


Subject(s)
Adhesins, Bacterial/physiology , Bacterial Outer Membrane Proteins/physiology , Bacterial Proteins/antagonists & inhibitors , Deoxycholic Acid/pharmacology , Porins/physiology , Vibrio cholerae/physiology , Adhesins, Bacterial/drug effects , Bacterial Outer Membrane Proteins/drug effects , Bacterial Proteins/drug effects , Electrophysiology , Humans , Hydrogen-Ion Concentration , Intestines/microbiology , Kinetics , Porins/antagonists & inhibitors , Porins/drug effects , Vibrio cholerae/drug effects
19.
Cell Death Differ ; 12(7): 751-60, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15818409

ABSTRACT

The role of the voltage-dependent anion channel (VDAC) in cell death was investigated using the expression of native and mutated murine VDAC1 in U-937 cells and VDAC inhibitors. Glutamate 72 in VDAC1, shown previously to bind dicyclohexylcarbodiimide (DCCD), which inhibits hexokinase isoform I (HK-I) binding to mitochondria, was mutated to glutamine. Binding of HK-I to mitochondria expressing E72Q-mVDAC1, as compared to native VDAC1, was decreased by approximately 70% and rendered insensitive to DCCD. HK-I and ruthenium red (RuR) reduced the VDAC1 conductance but not that of E72Q-mVDAC1. Overexpression of native or E72Q-mVDAC1 in U-937 cells induced apoptotic cell death (80%). RuR or overexpression of HK-I prevented this apoptosis in cells expressing native but not E72Q-mVDAC1. Thus, a single amino-acid mutation in VDAC prevented HK-I- or RuR-mediated protection against apoptosis, suggesting the direct VDAC regulation of the mitochondria-mediated apoptotic pathway and that the protective effects of RuR and HK-I rely on their binding to VDAC.


Subject(s)
Apoptosis , Porins/metabolism , Amino Acid Substitution/genetics , Animals , Apoptosis/drug effects , Binding Sites , Gene Expression , Hexokinase/genetics , Hexokinase/metabolism , Humans , Ion Channel Gating/drug effects , Mice , Mitochondria/metabolism , Porins/antagonists & inhibitors , Porins/chemistry , Porins/genetics , Rats , Recombinant Proteins/genetics , Ruthenium Red/pharmacology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , U937 Cells , Voltage-Dependent Anion Channel 1 , Voltage-Dependent Anion Channels
20.
Cell Death Differ ; 12(8): 1134-40, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15861186

ABSTRACT

Apoptotic cell death is an essential process in the development of the central nervous system and in the pathogenesis of its degenerative diseases. Efflux of K(+) and Cl(-) ions leads to the shrinkage of the apoptotic cell and facilitates the activation of caspases. Here, we present electrophysiological and immunocytochemical evidences for the activation of a voltage-dependent anion channel (VDAC) in the plasma membrane of neurons undergoing apoptosis. Anti-VDAC antibodies blocked the channel and inhibited the apoptotic process. In nonapoptotic cells, plasma membrane VDAC1 protein can function as a NADH (-ferricyanide) reductase. Opening of VDAC channels in apoptotic cells was associated with an increase in this activity, which was partly blocked by VDAC antibodies. Hence, it appears that there might be a dual role for this protein in the plasma membrane: (1) maintenance of redox homeostasis in normal cells and (2) promotion of anion efflux in apoptotic cells.


Subject(s)
Apoptosis/physiology , Caspases/metabolism , Neurons/metabolism , Porins/physiology , Adenosine Triphosphate/metabolism , Animals , Apoptosis/drug effects , Cell Line , Cell Membrane/metabolism , Cells, Cultured , Chloride Channels/physiology , Electrophysiology , Enzyme Activation , Hippocampus/cytology , Hippocampus/physiology , Humans , Immunoblotting , Immunochemistry , Mice , NADH, NADPH Oxidoreductases/metabolism , Neuroblastoma , Neurons/cytology , Neurons/enzymology , Patch-Clamp Techniques , Porins/antagonists & inhibitors , Porins/metabolism , Potassium Channels/physiology , Voltage-Dependent Anion Channel 1 , Voltage-Dependent Anion Channels
SELECTION OF CITATIONS
SEARCH DETAIL